Overview

Latest Financial Results

Stock Information

Symbol

Nasdaq: CRBP

Price

Loading...

Change

Loading...

MKT Cap

Loading...

Volume

Loading...

Company Overview

Corbus is committed to leveraging our expertise in immunology to fulfill our purpose of developing innovative new medicines that improve the lives of people living with inflammatory, fibrotic, and metabolic diseases, and cancer. Corbus’ current pipeline includes small molecules that activate or inhibit the endocannabinoid system and anti-integrin monoclonal antibodies that block activation of TGFβ. Corbus is headquartered in Norwood, Massachusetts.